Track: Thyroid Cancer / Parathyroid Disease

Thyroid Cancer / Parathyroid Disease

The session on Thyroid and Parathyroid Cancer will delve into the intricacies of these endocrine malignancies, which pose unique diagnostic and treatment challenges. Thyroid cancer, often detected through routine imaging or physical examination, encompasses a spectrum from indolent papillary cancers to aggressive anaplastic variants. Similarly, parathyroid cancer, though rare, requires precise management due to its potential to disrupt calcium homeostasis.

This session will explore groundbreaking advancements in the field, including:
  • Advances in Molecular Diagnostics: Harnessing genetic profiling for accurate classification and personalized treatment strategies.
  • Innovative Surgical Techniques: Emphasizing minimally invasive and robotic approaches to enhance surgical precision and patient recovery.
  • Evolving Role of Radioactive Iodine Therapy: Examining new applications and guidelines for its use in thyroid cancer management.
  • Emerging Targeted Therapies: Highlighting novel drugs and immunotherapeutic strategies for managing refractory and advanced thyroid and parathyroid cancers.
  • Complication Management: Addressing challenges such as recurrent laryngeal nerve injury and hypocalcemia with practical solutions.
  • Patient-Centric Insights: Discussing survivorship, long-term care, and improving the quality of life for patients navigating these complex conditions.

Session Overview
This session promises to offer a blend of research insights, clinical expertise, and practical solutions for improving patient care.Attendees will have the opportunity to engage with leading endocrinologists, surgeons, and oncologists to gain actionable knowledge and contribute to discussions on shaping the future of thyroid and parathyroid cancer management.